antalarmin has been researched along with Seizures in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashkenazi, S; Chrousos, GP; Ovadia, H; Weizman, A; Yuhas, Y | 1 |
| Grigoriadis, DE; Heinrichs, SC; McCarthy, JR | 1 |
1 review(s) available for antalarmin and Seizures
| Article | Year |
|---|---|
Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications.
Topics: Animals; Anxiety; Depression; Drug Design; Humans; Kinetics; Pyrimidines; Pyrroles; Receptors, Corticotropin-Releasing Hormone; Seizures; Substance-Related Disorders | 1999 |
1 other study(ies) available for antalarmin and Seizures
| Article | Year |
|---|---|
Involvement of the neuropeptide corticotropin-releasing hormone in an animal model of Shigella-related seizures.
Topics: Animals; Corticotropin-Releasing Hormone; Disease Models, Animal; Male; Mice; Mice, Inbred ICR; Pentylenetetrazole; Pyrimidines; Pyrroles; Seizures; Shigella; Time Factors | 2004 |